Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Minority Interest (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Minority Interest for 16 consecutive years, with -$336100.0 as the latest value for Q4 2025.

  • Quarterly Minority Interest fell 9.29% to -$336100.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$336100.0 through Dec 2025, down 9.29% year-over-year, with the annual reading at -$336100.0 for FY2025, 9.29% down from the prior year.
  • Minority Interest hit -$336100.0 in Q4 2025 for Cumberland Pharmaceuticals, down from -$319150.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of -$139283.0 in Q1 2021 to a low of -$343572.0 in Q4 2023.
  • Historically, Minority Interest has averaged -$277751.6 across 5 years, with a median of -$308605.5 in 2024.
  • Biggest five-year swings in Minority Interest: tumbled 195.44% in 2021 and later grew 10.49% in 2024.
  • Year by year, Minority Interest stood at -$212328.0 in 2021, then tumbled by 37.58% to -$292126.0 in 2022, then fell by 17.61% to -$343572.0 in 2023, then rose by 10.49% to -$307517.0 in 2024, then dropped by 9.29% to -$336100.0 in 2025.
  • Business Quant data shows Minority Interest for CPIX at -$336100.0 in Q4 2025, -$319150.0 in Q3 2025, and -$310868.0 in Q2 2025.